In Graves’ disease patients, an aberrant hypermethylation was observed for TRIM59, an aberrant hypomethylation for FHL2. In contrast, ELOVL2 and C1orf132 showed unchanged prediction accuracy in all disease groups. This evidence concerns the gene MIR29B2CHG and Graves disease.